During the past decade, Swenson, Wade II, MD (UIA Investigator) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 14 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Swenson, Wade II, MD (UIA Investigator)" #1 collaborator was "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Swenson, Wade II, MD (UIA Investigator)" are "Recurrent Breast Carcinoma" (3 trials), "Stage IV Breast Cancer AJCC v6 and v7" (3 trials), "Adult Glioblastoma" (2 trials), "Adult Gliosarcoma" (2 trials) and "Breast Adenocarcinoma" (2 trials). Many other conditions were trialed in "Swenson, Wade II, MD (UIA Investigator)" in a lesser frequency.

Most popular intervention types in "Swenson, Wade II, MD (UIA Investigator)" are "Drug" (16 trials), "Other" (12 trials), "Biological" (9 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Bevacizumab" (6 trials), "Quality-of-Life Assessment" (4 trials), "Questionnaire Administration" (3 trials) and "Sorafenib Tosylate" (3 trials). Other intervention names were less common.

The vast majority of trials in "Swenson, Wade II, MD (UIA Investigator)" are 14 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Swenson, Wade II, MD (UIA Investigator)". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Swenson, Wade II, MD (UIA Investigator), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Swenson, Wade II, MD (UIA Investigator), 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".